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Abstract
Purpose: The patient population that would benefit most from endovascular curative treatment of intracranial arteri-
ovenous malformations has not been clearly established. The aim of the study was to determine the effect of curative 
embolisation of cerebral arteriovenous malformations with special regard to radiographic and clinical outcomes and 
procedure-related complications.
Material and methods: Between January 2009 and December 2014, 18 patients with intracranial arteriovenous mal-
formations were embolised with Onyx with intent to cure. There were four women and 14 men, with a mean age 
of 40 years (range 10-62 years). Inclusion criteria were: maximal diameter of the lesions ≤ 3 cm and arterial supply 
consisting of no more than two major arteries. Five (27.8%) patients had ruptured lesions, and 13 (72.2%) patients 
had unruptured lesions. Mean arteriovenous malformation size was 2.3 cm (range 1.5-2.9 cm).
Results: Thirty-three procedures were performed in 18 patients. Total obliteration was achieved in five patients 
(27.8%). The most common reason for initial incomplete angiographic occlusion was unfavourable angioarchitec-
tural features of arteriovenous malformations, with the rate of 44.4%. The mean follow-up of patients with complete 
occlusion was 35.2 months (range 18-60 months). Complication rate was 12.1%. One patient had permanent neu-
rological deficit with resulting morbidity of 5.6%. There were no deaths.
Conclusions: Embolisation of intracranial arteriovenous malformations plays a limited role as a sole therapeutic mo-
dality even in terms of small lesions with two or fewer arterial feeders, although larger prospective series are necessary 
to confirm these findings. Associated complications are not trivial and should be considered when choosing this form 
of treatment.
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Introduction
Arteriovenous malformations (AVMs) are heterogene-
ous and infrequent vascular lesions that may be diagnosed 
following acute headache and neurological changes asso-
ciated with intracerebral haemorrhage as well as seizures, 
focal neurologic deficits, or headache elicited by unrup-
tured malformations [1-3]. It is reported that an increasing 
number of AVMs are detected incidentally [1, 3]. They all 
carry a risk of rupture resulting in significant morbidity 
and mortality [2]. When deciding to treat an AVM the 
therapeutic strategy includes surgical resection, radiosur-
gery, or endovascular technique – alone or in combina-
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tions [3-5]. As the two former are the mainstay of AVM 
treatment [6], the indications for the latter can be divid-
ed into embolisation before surgical excision in large or 
giant cortical AVMs, preradiosurgical management with 
the goal of reducing nidus size, and palliative therapy used 
to decrease high flow in large non-surgical and non-radio-
surgical AVMs with the intention of preserving or improv-
ing neurological function [1, 3]. Nonetheless, in selected 
cases, AVMs may be angiographically cured with the 
endo vascular approach performed as a “primary therapy” 
[2, 6-10]. To date, the patient population that would ben-
efit most from this form of treatment is not clearly estab-
lished due to considerable divergences between accessible 
publications [6]. The aim of the current study is to report 
our experience with the curative endovascular treatment of 
brain AVMs with special regard to radiographic and clini-
cal outcomes and procedure-related complications. 
Material and methods
Patients and arteriovenous malformations
Between January 2009 and December 2014 forty-two pa-
tients with AVMs were treated in 90 embolisation sessions 
at our institution. The group of 18 (42.9%) patients who 
were subjected to the treatment with intention to cure 
constitutes the patient cohort assessed in this report. In-
clusion criteria were: maximal diameter of AVMs less than 
3 cm and AVMs arterial supply consisting of no more 
than two major cerebral or cerebellar arteries. Arterio-
venous fistulas as well as aneurysms accompanying AVMs 
were excluded from this study. For this retrospective study 
Ethics Committee approval as well as informed patient 
consent were waived. There were four (22.2%) females and 
14 (77.8%) males with the age from 10 to 62 years (mean 
40 years, SD 14). Clinical presentation was intracranial 
haemorrhage in five (27.8%) out of 18 patients, neurolog-
ical deficits in five (27.8%) out of 18 patients, headaches in 
three (16.7%) out of 18 patients, and seizures in two (11%) 
patients. AVMs were incidentally diagnosed in three 
(16.7%) out of 18 patients. Among the five patients who 
presented with ruptured AVMs endovascular treatment 
procedures were performed within 1 to 27 (mean 8.6) 
days after the onset of symptoms. AVMs locations were: 
parieto-occipital region in seven (38.9%) patients, fron-
tal lobe in four (22.2%) patients, cerebellar hemisphere 
in three (16.7%) patients, basal ganglia and thalamus in 
two (11.1%) patients, temporal lobe in one (5.5%) patient, 
and perirolandic area in another one (5.5%). The size of 
the AVMs ranged from 1.5 cm to 2.9 cm (mean 2.3 cm SD 
0.4). The lesions were fed by one major cerebral or cere-
bellar artery in 10 (55.5%) out of 18 patients, and by two 
major cerebral or cerebellar arteries in the eight (44.5%) 
remaining ones. Based on the Spetzler-Martin score there 
were eight (44.5%) grade I AVMs, nine (50%) grade II 
AVMs, and one (5.5%) grade III AVM. 
Embolisation technique
Digital subtraction angiographies (DSA) performed on 
Philips Integris Allura 15C were obtained to evaluate ac-
curately the location of the nidus and the exact anatomy 
of the feeding arteries and draining veins. Endovascu-
lar embolisation was the first-line treatment method of 
all AVMs presented in the current study. All the proce-
dures were done by experienced interventional radi-
ologists, and always after neurosurgical consultations. 
The patients were treated under general anaesthesia. Af-
ter superselective transfemoral catheterisation of the AVM 
feeding pedicle, injection of the Onyx (ev3, Irvine, CA) 
was carried out with the intention of reaching the nidus 
of the AVM only, without occluding the arterial feeders 
or the draining veins. The flow-directed microcatheter 
Ultraflow (ev3) was always used. In cases of AVMs sup-
plied by two or more arterial pedicles staged embolisation 
was performed as a rule. During the procedures heparin-
ised saline was continuously infused into the arterial line. 
After embolisation, every patient was transferred to the 
intensive care unit for observation. Patients with unrup-
tured AVMs after uncomplicated treatment were typ-
ically discharged from hospital on postoperative day 3. 
The remaining patients were discharged from hospital 
after clinical stabilisation.
Clinical and angiographic evaluation
A control angiogram was always obtained immediate-
ly after the embolization and at minimum follow-up of 
4 weeks. The lack of contrast filling within the AVM ni-
dus was classified as a complete occlusion. Patients with 
incompletely occluded AVMs were offered radiosurgical 
or surgical therapy. Recanalisation was defined as any in-
crease in nidal filling at follow-up. In cases of revascular-
isation following initial complete occlusion of AVMs, the 
patients were retreated via endovascular approach or were 
referred to stereotactic radiotherapy and the decisions 
were made arbitrarily choosing the optimal strategy for 
an individual patient. Each time clinical evaluation was 
recorded on admission to hospital, directly after endovas-
cular procedure, at discharge from hospital, and during 
the last angiographic follow-up period.
Results
Angiographic results
In the 18 patients analysed in the study 33 endovascular 
treatment sessions were performed. The initial complete 
AVM occlusion was achieved in eight cases (44.4%) and 
it was obtained in 16 procedures. The primary incomplete 
occlusion of the remaining 10 AVMs resulted from diffi-
culties of accessing a nidus through arterial feeding arteries 
in eight patients (44.4%) and occurrence of complication 
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in another one (5.6%). One patient (5.6%) refused further 
treatment.
Angiographic follow-up was achieved in 15 (83.3%) 
patients and ranged from 1 to 60 months with a mean of 
13.8 months (SD 18.6). In 10 (66.7%) of 15 cases no change 
in the degree of occlusion at initial angiographic fol-
low-up was observed. Recanalisation occurred in three 
(20%) patients. Of these, two patients were retreated by 
Onyx embolisation therapy without any procedure-related 
complications. In two (13.3%) of the 15 followed patients, 
progressive occlusion was revealed. Complete occlusion of 
AVMs documented in control angiograms were achieved 
in five (33.3%) out of the 15 followed patients. Detailed 
data are presented in Table 1.
Clinical outcomes
Three (16.7%) patients out of 18 presented new focal neu-
rological deficits in the immediate postprocedural period. 
The deficits were temporary in two cases (11.1%) and per-
manent in one (5.6%). The both former patients presented 
with transient mild one-sided limb weakness, and in one 
case it was associated with intraoperative internal caro tid 
artery (ICA) stenosis. The endovascular procedure of the 
second patient with hemiparesis and AVM in basal ganglia 
was without complications. Instant post-embolisation con-
trol angiographies and computed tomography images were 
within normal limits, similarly to another patient who 
complained of progressive two-sided hearing deteriora-
tion following consecutive stages of cerebellar hemisphere 
AVM embolisations via bilateral posterior communicating 
arteries.
Complications
There were four (12.1%) adverse events out of 33 embo-
lisation sessions. In two cases the microcatheters were 
unintentionally glued to the vessels and broke during the 
Table 1. Summary of patients with arteriovenous malformations treated via endovascular approach with intent to cure
Patients AVMs Angiographic outcome
No Age/Sex Clinical 
presentation
Location Arterial 
feeders
Size 
(cm)
S-M Initial 
occlusion
No of 
sessions
Technical 
adverse 
events
Follow-up 
period
Occlusion 
at last 
follow-up 
1 10/M ICH Parieto-occipital PCA 2.1 2 Incomplete 2   8 Incomplete
2 24/F Hemiparesis Thalamus PCA 2.6 3 Incomplete 2 ICH 1 Incomplete
3 23/M Epilepsy Parieto-occipital MCA 2.7 2 Incomplete 2   3 Incomplete
4 24/F ICH Frontal ACA 1.5 1 Complete 3   24 Complete
5 31/F Headache Basal ganglia ACA 2 2 Complete 1   N/a due to lack of consent
6 34/M Headache Parieto-occipital ACA, PCA 2.6 2 Incomplete 1   N/a due to lack of consent
7 43/M ICH Frontal ACA 1.5 1 Complete 1   3 Incomplete
8 32/M Incidental Parieto-occipital MCA, PCA 2.2 2 Complete 2   N/a due to lack of consent
9 43/F ICH Cerebellar 
hemisphere
PICA, 
AICA
2.6 1 Incomplete 2   1 Incomplete
10 44/M Cerebellar 
syndrome
Cerebellar 
hemisphere
SCA 2.8 1 Incomplete 1 Material 
reflux
60 Complete
11 46/M Headache Parieto-occipital ACA, PCA 2.4 1 Complete 3   50 Complete
12 49/M Epilepsy Frontal ACA 1.7 1 Complete 2 Catheter 
gluing
6 Incomplete
13 48/M Cerebellar 
syndrome
Cerebellar 
hemisphere
PICA, 
AICA
2 1 Incomplete 2   3 Incomplete
14 51/M Cerebellar 
syndrome
Parieto-occipital PCA 2.2 2 Complete 3 Catheter 
gluing
3 Incomplete
15 53/M Incidental Perirolandic MCA 2,9 2 Incomplete 1   24 Complete
16 57/M Visual 
disturbance
Parieto-occipital MCA, PCA 2 2 Incomplete 1   1 Incomplete
17 59/M Incidental Temporal MCA, PCA 2.5 2 Incomplete 3   2 Incomplete
18 62/M ICH Frontal MCA, ACA 2.4 1 Complete 1   18 Complete
ACA – anterior cerebral artery, AICA – anterior inferior cerebellar artery, AVMs – arteriovenous malformations, ICH – intracerebral haemorrhage, MCA – middle cerebral artery, PCA – posterior 
cerebral artery, PICA – posterior inferior cerebellar artery, SCA – superior cerebellar artery, S-M – Spetzler-Martin grade
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removal attempt. The attached parts of the catheters were 
left in vertebral and internal carotid arteries, respective-
ly, resulting in partial occlusion of the latter vessel with 
subsequent transient mild hemiparesis. A clinically silent 
reflux of embolic material into posterior inferior cere-
bellar artery resulting in partial occlusion of this vessel 
was noted in a patient with cerebellar AVM. Immediately, 
20 mg of abciximab was injected locally with good angio-
graphic effect. As a consequence of intraprocedural AVM 
perforation, another patient experienced an asymptomatic 
minor intracerebral haemorrhage in the thalamus, which 
was treated conservatively. There was one case of rebleed-
ing five months after previous intracerebral haemorrhage 
in the occipital lobe and initial partial AVM embolisa-
tion. The patient was treated conservatively with good 
outcome, and then he was referred to complementary 
stereotactic radiosurgery.
Discussion
Endovascular treatment of patients with cerebral AVMs 
remains controversial and as a monotherapy plays a lim-
ited role in managing these lesions with intent to cure 
[6, 11], which is confirmed by the results of our study. 
Previous series have shown that the subgroup of patients 
that may benefit most from this form of therapy is based 
on morphological characteristics including small size, few 
supplying pedicles, and accessibility of the nidus [3, 6, 10, 
12]. However, the radiological factors associated with end-
ovascular complete AVM obliteration vary from study to 
study, and hitherto no consensus has been established 
with regard to the criteria for curative embolisation [6]. 
It is also worth mentioning that subtotal occlusion of 
AVMs achieved by some authors may not be considered 
therapeutic because it is widely known that it does not 
confer protection from haemorrhage [3, 9, 11]. What is 
more, there is published evidence that incompletely oblit-
erated AVMs may be associated with increased risk of 
bleeding [1]. Thus, only total occlusion of the nidus and 
the arteriovenous shunt constitutes a definitive cure for 
AVMs [13].
In the literature, the rate of complete obliteration of 
AVMs with the use of embolisation as one and only ther-
apeutic modality is up to 53.9%, depending on the patient 
selection, goals of treatment, and operative techniques 
[2, 10, 13]. The rate of total occlusion achieved by surgical 
resection and stereotactic radiotherapy is reported to be 
57.1-100% and 80%, respectively, although it should be 
noted that each of the two methods has its own indica-
tions and limitations [3]. Also, the AVMs that are most 
responsive to curative endovascular therapy overlap with 
those most amenable to surgical excision or radiosurgical 
ablation [2, 6, 10]. Nonetheless, in certain situations an 
endovascular approach could be undertaken. According 
to Potts et al., patients with contraindications to surgery, 
those in whom the haemorrhagic risk of radiosurgical 
latency period is too high, or those whose personal pref-
erence is embolisation are potential candidates for this 
form of treatment [6]. In order to achieve a satisfactory 
outcome from the use of embolisation the appropriate 
patient selection is crucial. Among the anatomical factors 
influencing the feasibility of curative AVM embolisation 
the accessibility of the nidus seems to be essential in terms 
of satisfactory initial obliteration. 
In the current study the main reason for incomplete 
angiographic occlusion during endovascular procedures 
was unfavourable angioarchitectural features of AVMs 
with the rate of 44.4%. Meanwhile, according to literature 
review by Potts et al., the immediate angiographic cure 
rates vary very widely from 5% to 94% [6]. Because all our 
procedures were performed via direct dominant arterial 
feeders, the next stage of embolization could not be con-
tinued if a nidus remnant was not reachable through this 
route (Figure 1D). 
In the literature there are data reporting that the pres-
ence of feeding arterial perforators, choroidal supply, “en 
passage” arterial feeders, and leptomeningeal collateral 
supply are associated with a lower cure rate [14]. Thus, to 
achieve better results the technical feasibility of total end-
ovascular obliteration should be assessed as best as pos-
sible on preoperative superselective angiograms [10, 15]. 
If an AVM remnant cannot be further treated via tran-
sarterial embolisation, a transvenous route may be the 
option, and the preliminary results are encouraging [6].  
Another issue related to endovascular therapy is re-
vascularisation that correlates strictly with the applied 
embolic agent [6]. Little is known about this phenome-
non in reference to AVMs, but it has been reported that 
it may even affect small lesions [2]. One of the reasons 
for AVM recurrence is proximal occlusion of the feeding 
artery without the appropriate penetration of embolic ma-
terial into the nidus, which results in the development of 
collateral circulation, although secondary angiogenesis is 
also probable [8, 13]. Taking the above into consideration, 
long-term angiographic follow-up after AVM embolisa-
tion is mandatory. It should be mentioned, however, that 
the optimal timing of angiography performed in order to 
exclude the AVM recanalisation has not yet beendeter-
mined [10].
In the event of incompletely obliterated AVMs, pro-
gressive spontaneous thrombosis may occur, as was ob-
served in two patients in the present study (Figure 1). 
This rare phenomenon is most likely to be associated with 
smaller AVM size, a single draining vein, and haemor-
rhage presentation, and hitherto it has been reported in 
untreated lesions, after partial surgical resection, as well 
as following subtotal embolisation of AVMs with isobutyl 
2-cyanoacrylate [8, 16-18]. 
Nevertheless, a residual AVM after surgery still has 
the ability to bleed or rebleed, so the rationale for the 
“wait-and-see” approach in subsets of AVM remnants 
after endovascular embolisation is rather unjustified 
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[19]. Moreover, even in terms of progressive thrombo-
sis, recanalisation may appear, so repeated control angio-
graphy should not be avoided [16, 17]. In the case of 
incomplete angiographic occlusion of AVMs the most 
common complementary treatment is reported to be radio-
surgery [13].
Nowadays, to occlude AVMs in the mechanism of 
thrombosis the non-adhesive liquid embolic agent ethylene 
vinyl alcohol copolymer dissolved in dimethyl sulfoxide, 
known as Onyx (ev3 Neurovascular, Irvine, CA), is com-
monly used during embolisation [6, 9]. The physical 
characteristics of Onyx compared with previous n-butyl- 
Figure 1. A 53-year-old man presented with in-
cidentally discovered arteriovenous malformation 
(AVM). Coronal (A) and sagittal (B) projections of 
computed tomography angiography demonstrat-
ed a right perirolandic AVM measuring 2.9 cm. 
Right internal carotid angiogram (C) before em-
bolisation showed the AVM that was supplied by 
the middle cerebral artery and drained into the 
superior sagittal sinus via a cortical vein. Instant 
post-embolisation angiogram (D) detected a re-
sidual portion of the nidus with persistent ve-
nous drainage (white arrow). The nidus remnant 
was not accessible through arterial pedicles, 
thus further embolisation was not possible. 
Anteroposterior (E) and lateral (F) right carotid 
angiograms taken eight months later revealed 
disappearance of the residual cluster and no evi-
dence of venous drainage, which was confirmed 
by control angiogram taken 16 months later (not 
shown)
A
C
E
D
F
B
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Figure 2. A 47-year-old man presented with increasing headaches. Anteroposterior and lateral left carotid angiograms (A) as well as anteroposterior and 
lateral left vertebral angiograms (B) demonstrated a left medial parieto-occipital arteriovenous malformation (AVM). The first session of embolisation was 
performed through the posterior cerebral artery (C) and the second and third ones through the anterior cerebral artery (D). Total occlusion of the AVM was 
achieved (E). The internal carotid and vertebral angiograms taken 50 months after endovascular treatment revealed no recanalisation, which is presented 
in oblique projections (F)
A
C D
E F
B
cyano acrylate glue allow more prolonged and controlled 
injections, which has a positive impact on penetration 
into the nidus [6, 9, 11, 20]. This property, however, pre-
disposes to improper reflux of Onyx, which may result 
in inadvertent occlusion of normal arterial branches or 
catheter entrapment [9, 11]. It is important to know that 
the presence of branches arising from a specific arterial 
pedicle and supplying normal brain tissue limits AVM 
embolisation via this pedicle due to risk thrombosis [9]. 
In both cases of catheter gluing described in our series, 
we attempted to remove them by applying traction, which 
resulted in breakage of the catheters. Although the pa-
tients did not present any serious clinical consequenc-
es and the follow-up angiograms were within normal 
limits, studies suggest leaving the trapped catheter in 
place and cutting it off at the groin sheath, because ex-
cessive attempts to withdraw it may induce haemorrhage 
[9, 11]. Leaving a catheter extending down the descend-
ing aorta is reasonably safe and delayed complications are 
sporadic [21]. A microcatheter broken above the level of 
the aortic arch poses a risk of becoming an embolus to 
the intracranial circulation, so it should be pulled with the 
use of a microsnare or secured with a self-expanding stent 
[21]. Surgical removal of the glued catheter may result in 
severe brain infarction, so it is rational only in selected 
cases [10, 21]. As far as conservative treatment is con-
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cerned, it should be noted that the need to put a patient 
with a retained catheter in the body under anticoagulation 
has not yet been unequivocally established [10, 11].
One of the most important complications of AVM 
endovascular therapy is haemorrhage, which can be in-
traoperative and postoperative and may be caused by 
several factors [21]; AVM bleeding associated with vein 
stenosis or occlusion and subsequent active arterial supply 
to the lesion without adequate venous outflow is one of 
them [9]. The intracerebral haematoma may sometimes 
require surgical intervention and the clinical sequelae 
can be fatal [9, 22]. The haematoma as well as brain oede-
ma may also result from the so-called normal perfusion 
pressure breakthrough syndrome (NPPBS)  in which in-
creased blood flow towards the normal brain vessels after 
AVM embolisation is observed [6, 9, 21]. To lower the 
risk of this negative phenomenon, staged embolisation of 
AVMs is considered, in order to ensure the recovery of the 
brain between procedures, especially in the case of large 
AVMs [9, 23]. In 18 patients demonstrated in this study 
we performed 33 embolisation sessions, and none of the 
patients developed symptoms of NPPBS (Figure 2). None-
theless, one patient of our cohort experienced intracer-
ebral bleeding five months after the first stage of AVM 
embolisation. In the literature, the usefulness of staged 
embolisation is still debatable, and although it is sup-
posed to lower periprocedural haemorrhagic complica-
tions, leaving a residual shunt after the procedure always 
harbours a certain risk of subsequent AVM bleeding, 
especially when the venous outlet is occluded [13, 21]. 
Taking the above into account, in our opinion the need 
of multiple embolisation sessions is a serious limitation 
of endovascular treatment of AVMs as a monotherapy. 
Because prolonged time of treatment may be associated 
with persisting risk of intracerebral haemorrhage, the pa-
tient selection for embolisation as a sole therapeutic tool 
for AVM treatment should be highly weighted.    
In conclusion, this study found that endovascular 
management of brain AVMs as a sole therapeutic modal-
ity plays a limited role even in terms of small (< 3 cm) 
lesions with a maximum of two arterial feeders, and it 
should be applied only in exceptional cases, although 
larger prospective series are necessary to confirm these 
findings. Although Onyx embolisation has the potential 
to be relatively safe, periprocedural complications should 
not be neglected when selecting this form of treatment.
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